Effects of TGFbeta1 on gene expression in the HP75 human pituitary tumor cell line identified by gene expression

Katharina H Ruebel1, Alexey A Leontovich, Yoshinori Tanizaki

  • 1Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street, SW, Rochester, MN, 55905, USA.

Endocrine
|April 11, 2008
PubMed

Insights

Transforming growth factor-beta (TGFβ) impacts pituitary tumor cell growth by altering gene expression. This study reveals TGFβ influences diverse gene networks, including those interacting with Galectin-3, impacting pituitary adenoma development.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • The precise mechanisms driving pituitary adenoma pathogenesis and growth remain largely unknown.
  • Transforming growth factor-beta (TGFβ) is recognized for inhibiting anterior pituitary cell and tumor proliferation, yet its signal transduction pathways are not fully elucidated.

Purpose of the Study:

  • To investigate the global gene expression changes in a human pituitary cell line following TGFβ1 treatment.
  • To identify specific genes and pathways regulated by TGFβ1 that influence pituitary tumor cell growth.

Main Methods:

  • Global gene expression profiling using Affymetrix GeneChip microarray analysis on the HP75 pituitary cell line treated with TGFβ1.
  • Quantitative PCR was employed for validating specific gene expression alterations.

Main Results:

  • TGFβ1 treatment led to significant alterations in the expression of numerous genes, with hundreds of genes being up-regulated or down-regulated at various time points (4, 24, and 96 hours).
  • Key findings include decreased Galectin-3 (Gal-3) protein levels and up-regulation of interacting genes like RUNX1 and WNT5B, as well as SOX4.
  • Notably, SMAD3, a crucial component of the TGFβ signaling pathway, was down-regulated by TGFβ1 treatment.

Conclusions:

  • TGFβ exerts its inhibitory effects on pituitary tumor cells through complex and diverse gene networks.
  • The study elucidates novel pathways involved in TGFβ-mediated regulation of pituitary cell growth, offering insights into pituitary adenoma pathogenesis.